Patents by Inventor Kevin Edward Leif Wilhelmsen

Kevin Edward Leif Wilhelmsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20240067610
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: July 17, 2023
    Publication date: February 29, 2024
    Inventors: George HARTMAN, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20240059659
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: July 17, 2023
    Publication date: February 22, 2024
    Inventors: George HARTMAN, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20240051923
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: July 17, 2023
    Publication date: February 15, 2024
    Inventors: George HARTMAN, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20230365507
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: May 25, 2023
    Publication date: November 16, 2023
    Inventors: George HARTMAN, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • Inhibitors of NLRP3 inflammasome
    Patent number: 11708334
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging; wherein the inhibitors of NLRP3 inflammasomes are compounds of Formula VII: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: July 25, 2023
    Assignee: BIOAGE LABS, INC.
    Inventors: George Hartman, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • Inhibitors of NLRP3 inflammasome
    Patent number: 11702391
    Abstract: The present disclosure relates to compounds of Formula I: that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Grant
    Filed: March 23, 2022
    Date of Patent: July 18, 2023
    Assignees: BIOAGE LABS, INC., HITGEN, INC.
    Inventors: George Hartman, Xu He, Jia Du, Lifang Zhang, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20230051130
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: September 9, 2022
    Publication date: February 16, 2023
    Inventors: George HARTMAN, Paul Humphries, Kevin Edward Leif Wilhelmsen
  • INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20220324812
    Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
    Type: Application
    Filed: March 23, 2022
    Publication date: October 13, 2022
    Inventors: George HARTMAN, XU HE, JIA DU, LIFANG ZHANG, Paul Humphries, Kevin Edward Leif Wilhelmsen